Literature DB >> 565893

Active state properties of denervated and immobilized muscle: comparison with dystrophic muscle.

M Takamori, R Hazama, M Tsujihata.   

Abstract

Possible roles of neurotrophic mechanisms and muscle activity in the contractile abnormalities of muscular dystrophy were studied by comparing human dystrophic muscle to denervated and immobilized muscle. As evident in denervated muscle from the decreased acceleration of twitch development (decreased active state intensity of shortening), and isoproterenol-induced decrease of twitch with shortened decay of the active state, part of the abnormality in the subcellular calcium transport system in dystrophic muscle seems to be influenced by disordered neural regulation. Other active state abnormalities relating to activation processes and contractile proteins in dystrophic muscle were also demonstrated in both denervated and immobilized muscle, with some being more marked in immobilized muscle. The findings indicate that a neurogenic hypothesis cannot entirely explain the pathogenesis of progressive muscular dystrophy.

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 565893     DOI: 10.1212/wnl.28.6.603

Source DB:  PubMed          Journal:  Neurology        ISSN: 0028-3878            Impact factor:   9.910


  4 in total

1.  Neuromuscular function in limb girdle dystrophy.

Authors:  A Y Belanger; A J McComas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1985-12       Impact factor: 10.154

2.  Contractile properties of muscles in myotonic dystrophy.

Authors:  A Y Belanger; A J McComas
Journal:  J Neurol Neurosurg Psychiatry       Date:  1983-07       Impact factor: 10.154

3.  Morphometric ultrastructural study of the regeneration of soleus muscle in hypokinesia.

Authors:  W Barańska; M Marciniak; W Baran
Journal:  Cell Tissue Res       Date:  1983       Impact factor: 5.249

4.  Nonlinear summation of contractions in striated muscle. I. Twitch potentiation in human muscle.

Authors:  J Duchateau; K Hainaut
Journal:  J Muscle Res Cell Motil       Date:  1986-02       Impact factor: 2.698

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.